ChemDiv is a pioneering company specializing in chemical compound libraries and innovative drug discovery solutions. With an extensive catalog comprising over 1.5 million screened compounds, ChemDiv offers comprehensive resources for researchers in the field of medicinal chemistry. Their extensive screening libraries include GPCR-Targeted and Peptidomimetic libraries, which enable high-precision virtual screening for potential drug candidates.

ChemDiv's offerings also feature advanced tools such as the DeepGPCR platform, which revolutionizes GPCR–ligand predictions, significantly enhancing the drug discovery process. The company collaborates with renowned research institutions and participates in various publications, showcasing the effectiveness of their compounds in real-world applications.

By providing access to a diverse range of bioactive libraries and advanced structure search capabilities, ChemDiv supports scientists in identifying novel therapeutics across various therapeutic areas, including ion channel and enzyme inhibitors. Their commitment to innovation and quality empowers researchers to push the boundaries of drug discovery and realize their therapeutic goals.